Beyond Treatment Volume: When Pelvic Radiotherapy May Still Matter in High-Risk Localised Prostate Cancer - Top-Institutions - MDSpire

Beyond Treatment Volume: When Pelvic Radiotherapy May Still Matter in High-Risk Localised Prostate Cancer

  • By

  • Henriquez, Ivan

  • Abuchaibe, Oscar

  • Malave-Chacon, Barbara

  • Arenas, Meritxell

  • April 27, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLA

    Los Angeles, CA

    Key Differentiators

    • Oncology

  • #2

    MARCAP Consortium
    MARCAP Consortium

    International

    Key Differentiators

    • Oncology

  • #3

    GETUG
    GETUG

    France

    Key Differentiators

    • Oncology

  • #4

    EORTC
    EORTC

    Belgium

    Key Differentiators

    • Oncology

  • #5

    NRG/RTOG
    NRG/RTOG

    United States

    Key Differentiators

    • Oncology

Original Source(s)

Beyond Treatment Volume: When Pelvic Radiotherapy May Still Matter in High-Risk Localised Prostate Cancer

  • by Henriquez, Ivan , Abuchaibe, Oscar , Malave-Chacon, Barbara , Arenas, Meritxell

  • April 27, 2026

Related Content

Dosimetric Evaluation of IMRT and VMAT Techniques with Deep Inspiration Breath Hold versus Free Breathing for Whole Breast Irradiation on the Right Side

When Adnexal Lymphoma Mimics Retinal Disease

DARE-FUSE: domain aligned evidence guided learning for joint brain tumor MRI segmentation and classification